A Research Study Looking at the Comparability (Bioequivalence) of Two Versions of Semaglutide

NCT04228354 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Overweight
Obesity

Interventions

DRUG: Semaglutide

Sponsor

Novo Nordisk A/S